Immune activation, Cd4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Kitchen, Christina M R ^a   Yeghiazarian, Lilit ^a,b   Hoh, Rebecca ^c   McCune, Joseph M ^c   Sinclair, Elizabeth ^c   Martin, Jeffrey N ^c   Deeks, Steven G ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; LOPINAVIR PLUS RITONAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL POPULATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREDICTION; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS LOAD; GENETICS; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; VIREMIA;

EID: 79959315802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021190     Document Type: Article

References (47)

1. Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, et al. (2004) Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 364: 51-62.
2. Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM, (2000) Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis 181: 946-953.
3. Vaidya N, Rong L, Marconi V, Kuritzkes DR, Deeks SG, et al. (2010) Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load. PLOS Computational Biology 6: e1001012.
4. Petersen ML, van der Laan MJ, Napravnik S, Eron JJ, Moore RD, et al. (2008) Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. AIDS 22: 2097-2106.
5. Penn ML, Myers M, Eckstein DA, Leigler TJ, Hayden M, et al. (2001) Primary recombinant HIV-1 strains resistance to protease inhibitors are pathogenic in mature human lymphoid tissues. AIDS Research Human Retroviruses 17: 517-523.
6. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, et al. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296: 1498-1506.
7. Mellors JW, Margolick JB, Phair JP, Rinaldo CR, Detels R, et al. (2007) Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. Jama 297: 2349-2350.
8. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, et al. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
9. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
10. Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, et al. (2006) The independent effect of drug resistance on T cell activation in HIV infection. AIDS 20: 691-699.
11. Bloomfield P, (2000) Fourier Analysis of Time Series: An Introduction; In: Shewart W, Wilks S, editors. New York John Wiley & Sons, Inc.
12. Emu B, Sinclair E, Favre D, Moretto W, Hsue P, et al. (2005) Phenotypic, functional and kinetic parameters associated with apparent T-cell control in Human Immunodeficiency Virus replication in individuals with and without antiretroviral treatment. Journal of Virology 79: 14169-14178.
13. Sterne J, White I, Carlin J, Spratt M, Kenward M, et al. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. British Medical Journal 338: b2393.
14. White I, Carlin J, (2010) Bias and efficiency of multiple imputation compared with complete-case analysis or missing covariate values. Statistics in Medicine 29: 1920-2931.
15. Spratt M, Carpenter J, Sterne J, Carlin J, Heron J, et al. (2010) Strategies for multiple imputation in longitudinal studies. American Journal of Epidemiology 172: 478-487.
16. Lee H, Kashyap V, van Dyk D, Connors A, Drake J, et al. (2011) Accounting for calibration uncertainties in X-ray analysis: effective areas in spectral fitting. The Astrophysical Journal In Press.
17. Hopke P, Liu C, Rubin DB, (2001) Multiple imputation for multivariate data with missing and below-threshold measurements: time-series concentrations of pollutants in the arctic. Biometrics 57: 22-33.
18. Rubin DB, (1996) Multiple imputation after 18+ years (with discussion). Journal of the American Statistical Association 91: 473-489.
19. Broersen P, de Waele S, Bos R, (2004) Autoregressive spectral analysis when observations are missing. Automatics 40: 1495-1504.
20. Graham JW, Olchowski AE, Gilreath TD, (2007) How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science 8: 206-213.
21. Press WH, Flannery BP, Teukolsky SA, Vetterling WT, (1992) Numerical recipes in C: The art of scientific computing: Cambridge University Press.
22. Beal S, Sheiner L, (1982) Estimating population kinetics. Critical Reviews in Biomedical Engineering 8: 195-222.
23. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, et al. (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355.
24. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, et al. (1998) CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 18: 332-340.
25. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy. J Infect Dis 187: 1534-1543.
26. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL, (2007) Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117: 3148-3154.
27. Bonhoeffer S, Coffin JM, Nowak MA, (1997) Human immunodeficiency virus drug therapy and virus load. J Virol 71: 3275-3278.
28. Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, et al. (2008) HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci U S A 105: 19851-19856.
29. Silvestri G, Sodora D, Koup R, Pajardini M, O'Neil S, et al. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-452.
30. Hazenberg M, Otto S, van Benthem B, Roos M, Coutinho R, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
31. Tesselaar K, Arens R, van Schijndel G, Baars P, van der Valk M, et al. (2003) Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nature Immunology 4: 49-54.
32. Suntharalingam G, Perry M, Ward S, Brett S, Castello-Cortes A, et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New England Journal of Medicine 355: 1018-1028.
33. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, et al. (2009) Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 48: 350-361.
34. Bonhoeffer S, Coffin JM, Nowak MA, (1997) Human immunodeficiency virus drug therapy and virus load. Journal of Virology 71: 3275-3278.
35. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, et al. (1995) Viral dynamics in HIV-1 infection. Nature 373: 117-122.
36. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, et al. (1995) Rapid turnover of plasma virions CD4+ lymphocytes in HIV-1 cells. Nature 373: 123-126.
37. Spouge JL, Shrager RI, Dimitrov DS, (1996) HIV-1 infection kinetics in tissue cultures. Mathematical Biosciences 138: 1-22.
38. Nowak MA, Bangham CRM, (1996) Population dynamics of immune responses to persistent viruses. Science 272: 74-79.
39. Phillips MN, McLean A, Johnson MA, Tyrer M, Emercy V, et al. (1997) HIV-1 dynamics after transient antiviral therapy: implications for pathogenesis and clinical management. Journal of Medical Virology 53: 261-265.
40. Perelson AS, Kirschner DE, De Boer R, (1993) Dynamics of HIV infection in CD4+ T cells. Mathematical Biosciences 114: 81-125.
41. Anderson RM, May RM, (1991) Infectious disease of humans: dynamics and control: Oxford Science Publications.
42. Hales S, Weinstein P, Souares Y, Woodward A, (1999) El nino and the dynamics of vector borne disease transmission. Environmental Health Perspectives 107: 99-102.
43. Lindblade K, Walker E, Onapa A, Katungu J, Wilson M, (1999) Highland malaria in Uganda: prospective analysis of an epidemic associated with El Nino. Transactions of the Royal Society of Tropical Medicine and Hygiene 93: 480-487.
44. Bouma MJ, Van der Kaay H, (1996) The El Nino southern oscillation and the historic malaria epidemics on the Indian subcontinent and Sri Lanka: an early warning system for future epidemics? Tropical Medicine and International Health 1: 86-96.
45. Reuman DC, Desharnais RA, Constantino RF, Ahmad OS, Cohen JE, (2006) Power spectra reveal the influence of stochasticity on nonlinear population dynamics. Proceedings of the National Academy of Sciences USA 103.
46. Havlir DV, Marschner IC, Hirsch MS, Collier AC, Tebas P, et al. (1998) Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med 339: 1261-1268.
47. Grossman Z, Feinberg MB, Paul WE, (1998) Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc Natl Acad Sci U S A 95: 6314-6319.